Hit enter to search or ESC to close

logo-block
alva
Get in touch
logo-block-tablet

Coronavirus

alva’s Covid-19 resources showcase the actions of organisations that are putting stakeholders first – community, customers, colleagues – when dealing with the pandemic.

ESG Intelligence ESG Intelligence – Pharmaceuticals – 1st August to 24th November 2020

ESG Intelligence – Pharmaceuticals – 1st August to 24th November 2020

In the second of our monthly ESG sector profiles, we see the Pharma industry enter positive territory with an average score of +10. Four out of nine...
Read more
Coronavirus COVID-19 Monthly Insight, October 06 – November 06 2020

COVID-19 Monthly Insight, October 06 – November 06 2020

This month sees companies wrestling with how to approach the holiday season and how much deference they need to pay to the Covid-shaped elephant in...
Read more
ESG Intelligence ESG Intelligence – Global Mining and Metals – Q3 2020

ESG Intelligence – Global Mining and Metals – Q3 2020

In the first of our monthly ESG sector profiles, we see the Mining sector average fall this quarter with a score of -6. Negativity is mainly driven...
Read more
Coronavirus COVID-19 Weekly Insight, September 29 – October 05 2020

COVID-19 Weekly Insight, September 29 – October 05 2020

COVID-19 has introduced the need for a different type of leadership and business executives are demonstrating qualities of flexibility, vision and a...
Read more
Coronavirus COVID-19 Weekly Insight, September 22 – 28 2020

COVID-19 Weekly Insight, September 22 – 28 2020

Brexit dominates Covid discussion in the UK, with further signs of companies shifting away from the country and corresponding concerns over future...
Read more
Coronavirus COVID-19 Weekly Insight, September 15 – 21 2020

COVID-19 Weekly Insight, September 15 – 21 2020

As fears grow of a second lockdown and a number of workplace outbreaks cause rethinks to office reopenings, businesses are once again in the...
Read more

In the second of our monthly #ESG sector profiles, we see the #Pharma industry enter positive territory with an average score of +10. Four out of nine material issue areas score negatively in Q3, driven by Affordability & Pricing (-22%)
👇Download report: https://t.co/ud1gia4FtA

2020 has taught us that resilience and flexibility are the hallmarks of a sustainable business. Strong ESG performance lies at the core of that sustainability, and firms that can manage their #ESG liability will be the ones that thrive in the future.
https://t.co/taQrhpko5M

The rise of stakeholder capitalism is being thrown into sharp focus through the #ESG lens. Each #stakeholder group encompasses its own risks and opportunities, and businesses need to be able to track and respond to them all #stakeholdercapitalism
👉 https://t.co/sgGfBVXc2H

Load More...

COVID-19
Insights from the Existential Phase

alva's COVID-19 Insights from the Existential Phase report showcases the actions and organisations that are putting stakeholders first – community, customers, colleagues – when dealing with the pandemic.

To receive our COVID-19 Insights from the Existential Phase report simply complete the form below. Stay safe.